Contributors |
|
xxxiii | |
Preface: The History of Esophagology |
|
xxxvii | |
|
About the Companion Website |
|
xxxviii | |
Part I Esophageal Symptoms |
|
1 | (58) |
|
1 Symptom Overview and Quality of Life |
|
|
3 | (15) |
|
|
|
3 | (1) |
|
Esophageal anatomy and production of symptoms |
|
|
3 | (1) |
|
|
3 | (1) |
|
Esophageal muscle and sphincters |
|
|
4 | (1) |
|
Development of esophageal symptoms |
|
|
4 | (1) |
|
|
4 | (6) |
|
|
5 | (1) |
|
Patient history and physical examination |
|
|
6 | (1) |
|
|
6 | (1) |
|
|
6 | (1) |
|
|
7 | (1) |
|
Heartburn and regurgitation |
|
|
8 | (1) |
|
|
8 | (1) |
|
|
9 | (1) |
|
GERD and extraesophageal symptoms |
|
|
9 | (1) |
|
Healthcare utilization and quality of life |
|
|
10 | (3) |
|
Symptom and quality of life assessment tools |
|
|
10 | (3) |
|
|
13 | (1) |
|
|
13 | (5) |
|
2 Diagnosis and Treatment of Esophageal Chest Pain |
|
|
18 | (20) |
|
|
|
|
|
18 | (1) |
|
|
18 | (1) |
|
|
19 | (2) |
|
|
19 | (1) |
|
|
19 | (2) |
|
|
21 | (1) |
|
Esophageal hypersensitivity |
|
|
21 | (6) |
|
|
21 | (3) |
|
|
24 | (1) |
|
|
24 | (1) |
|
|
25 | (1) |
|
|
27 | (1) |
|
|
27 | (2) |
|
|
27 | (1) |
|
|
27 | (1) |
|
|
28 | (1) |
|
|
28 | (1) |
|
Hypercontractile (jackhammer) esophagus |
|
|
28 | (1) |
|
|
28 | (1) |
|
Available treatment options for esophageal chest pain |
|
|
29 | (1) |
|
|
29 | (1) |
|
Endoscopic and surgical management |
|
|
29 | (1) |
|
|
30 | (1) |
|
|
31 | (7) |
|
3 Disorders Causing Oropharyngeal Dysphagia |
|
|
38 | (15) |
|
|
|
|
38 | (1) |
|
|
39 | (4) |
|
|
39 | (2) |
|
|
41 | (1) |
|
Sensory afferent pathways |
|
|
41 | (1) |
|
Central organizing center |
|
|
41 | (1) |
|
|
42 | (1) |
|
|
42 | (1) |
|
|
43 | (1) |
|
|
44 | (2) |
|
|
44 | (1) |
|
|
44 | (1) |
|
|
44 | (1) |
|
|
44 | (1) |
|
|
45 | (1) |
|
|
45 | (1) |
|
|
46 | (1) |
|
|
46 | (3) |
|
Endoscopic and surgical management |
|
|
46 | (1) |
|
Swallowing and postural techniques |
|
|
47 | (1) |
|
Swallowing maneuvers and exercises |
|
|
47 | (1) |
|
|
48 | (1) |
|
|
48 | (1) |
|
|
49 | (1) |
|
|
49 | (1) |
|
|
49 | (1) |
|
|
49 | (4) |
|
4 The Esophagus: Rumination Syndrome |
|
|
53 | (6) |
|
|
|
|
53 | (1) |
|
Definition, clinical presentation, and demographic characteristics |
|
|
53 | (1) |
|
|
53 | (1) |
|
|
54 | (1) |
|
|
55 | (1) |
|
|
55 | (2) |
|
|
55 | (1) |
|
|
56 | (1) |
|
|
56 | (1) |
|
|
57 | (1) |
|
|
57 | (1) |
|
|
57 | (2) |
Part II Esophageal Physiology and Testing |
|
59 | (188) |
|
5 Functional Anatomy and Physiology of Swallowing and Esophageal Motility |
|
|
61 | (36) |
|
|
|
|
61 | (1) |
|
|
61 | (4) |
|
Swallowing pattern generator |
|
|
62 | (1) |
|
Organizational structure and function |
|
|
62 | (1) |
|
|
63 | (1) |
|
|
63 | (1) |
|
|
63 | (1) |
|
Cortical and supramedullary influences |
|
|
64 | (1) |
|
Oropharyngeal stage motor activity |
|
|
64 | (1) |
|
|
65 | (1) |
|
Protection of the nasal cavity |
|
|
65 | (1) |
|
|
65 | (1) |
|
Upper esophageal sphincter |
|
|
65 | (5) |
|
|
65 | (2) |
|
Functional motor activity |
|
|
67 | (1) |
|
|
67 | (1) |
|
|
68 | (1) |
|
Esophagopharyngeal reflexes |
|
|
69 | (1) |
|
Esophageal stage motor activity |
|
|
70 | (8) |
|
|
70 | (1) |
|
Anatomy, structure, and innervation |
|
|
70 | (1) |
|
|
71 | (1) |
|
|
71 | (1) |
|
Functional motor activity |
|
|
71 | (1) |
|
|
71 | (1) |
|
|
72 | (1) |
|
|
73 | (1) |
|
Afferent sensory stimulation |
|
|
73 | (1) |
|
|
74 | (1) |
|
Smooth muscle esophageal body: motor activity |
|
|
74 | (1) |
|
Central control mechanisms |
|
|
74 | (1) |
|
Intramural neural control mechanisms |
|
|
75 | (1) |
|
Intramural myogenic (muscle) control mechanisms |
|
|
76 | (1) |
|
Integration of central and peripheral mechanisms |
|
|
77 | (1) |
|
|
77 | (1) |
|
Lower esophageal sphincter |
|
|
78 | (5) |
|
|
78 | (1) |
|
Phrenoesophageal membrane |
|
|
78 | (1) |
|
|
78 | (1) |
|
Intrinsic lower esophageal sphincter |
|
|
78 | (2) |
|
Functional motor activity |
|
|
80 | (1) |
|
Resting or basal pressure |
|
|
80 | (1) |
|
Transient lower esophageal sphincter relaxations |
|
|
82 | (1) |
|
|
82 | (1) |
|
|
83 | (14) |
|
6 Radiology of the Pharynx and Esophagus |
|
|
97 | (51) |
|
|
|
|
97 | (1) |
|
|
97 | (17) |
|
Normal pharyngeal anatomy |
|
|
97 | (2) |
|
Normal oral and pharyngeal motility |
|
|
99 | (2) |
|
|
101 | (2) |
|
|
103 | (1) |
|
|
103 | (1) |
|
Killian-Jamieson diverticula and pouches |
|
|
106 | (1) |
|
Lateral pharyngeal pouches and diverticula |
|
|
107 | (1) |
|
Branchial pouch sinuses and branchial cleft fistulae |
|
|
107 | (1) |
|
|
108 | (1) |
|
|
108 | (1) |
|
Pharyngeal and cervical esophageal webs |
|
|
108 | (2) |
|
|
110 | (1) |
|
|
110 | (1) |
|
|
110 | (1) |
|
|
113 | (1) |
|
|
113 | (1) |
|
|
114 | (29) |
|
|
114 | (1) |
|
Gastroesophageal reflux disease |
|
|
115 | (1) |
|
|
115 | (1) |
|
|
116 | (1) |
|
|
117 | (4) |
|
|
121 | (1) |
|
|
121 | (1) |
|
|
122 | (1) |
|
Cytomegalovirus esophagitis |
|
|
123 | (1) |
|
Human immunodeficiency virus esophagitis |
|
|
123 | (1) |
|
|
123 | (2) |
|
|
125 | (1) |
|
|
125 | (1) |
|
|
126 | (1) |
|
|
126 | (1) |
|
|
127 | (1) |
|
|
128 | (1) |
|
|
128 | (1) |
|
|
128 | (1) |
|
|
128 | (1) |
|
|
129 | (1) |
|
|
129 | (1) |
|
|
130 | (1) |
|
|
131 | (1) |
|
|
131 | (1) |
|
|
134 | (1) |
|
|
134 | (1) |
|
|
135 | (1) |
|
|
138 | (1) |
|
|
138 | (1) |
|
Esophageal intramural pseudodiverticula |
|
|
138 | (1) |
|
Esophageal motility disorders |
|
|
139 | (1) |
|
|
139 | (1) |
|
|
140 | (1) |
|
|
140 | (1) |
|
|
140 | (1) |
|
|
141 | (1) |
|
|
142 | (1) |
|
|
143 | (1) |
|
|
143 | (5) |
|
7 Special Endoscopic Imaging and Optical Techniques for Evaluating the Esophagus |
|
|
148 | (7) |
|
|
|
|
|
149 | (1) |
|
Electronic chromoendoscopy |
|
|
149 | (1) |
|
Confocal laser endomicroscopy (CLE) |
|
|
149 | (4) |
|
Volumetric laser endomicroscopy (VLE) |
|
|
153 | (1) |
|
|
153 | (1) |
|
|
153 | (2) |
|
8 High-Resolution Manometry and Esophageal Pressure Topography |
|
|
155 | (17) |
|
|
|
|
155 | (1) |
|
|
155 | (1) |
|
Indications for esophageal manometry |
|
|
155 | (1) |
|
Manometry study technique and protocol |
|
|
155 | (2) |
|
|
155 | (1) |
|
Patient selection and preparation |
|
|
156 | (1) |
|
Manometry catheter placement |
|
|
156 | (1) |
|
|
157 | (1) |
|
|
157 | (1) |
|
Interpretation of high-resolution manometry and esophageal pressure topography |
|
|
157 | (6) |
|
Step 1: Evaluate EGJ morphology and tone |
|
|
158 | (1) |
|
Step 2: Apply HRM metrics to individual swallows |
|
|
159 | (1) |
|
Step 3: Classify individual test swallows |
|
|
160 | (1) |
|
Step 4: Step designation of an esophageal motility diagnosis |
|
|
161 | (2) |
|
HRM/EPT beyond the Chicago classification |
|
|
163 | (4) |
|
Application of esophageal manometry to gastroesophageal reflux disease: The Lyon Consensus |
|
|
163 | (1) |
|
High-resolution impedance manometry (HRIM) |
|
|
163 | (2) |
|
Application of adjunctive or provocative maneuvers |
|
|
165 | (2) |
|
|
167 | (1) |
|
|
167 | (5) |
|
9 Esophageal Testing Using Multichannel Intraluminal Impedance |
|
|
172 | (16) |
|
|
|
|
172 | (1) |
|
|
172 | (1) |
|
High-resolution impedance manometry |
|
|
173 | (1) |
|
Esophageal function testing using combined multichannel intraluminal impedance and manometry |
|
|
173 | (1) |
|
Multichannel intraluminal impedance for assessment of bolus transit in esophageal function tests |
|
|
174 | (2) |
|
Combined MII-EM in belching and rumination |
|
|
176 | (2) |
|
Combined multichannel intraluminal impedance and pH for detection of acid and nonacid gastroesophageal reflux |
|
|
178 | (6) |
|
MII-pH catheter characteristics and placement |
|
|
180 | (1) |
|
|
180 | (2) |
|
|
182 | (1) |
|
Assessment of mucosal integrity using baseline impedance measured by MII-pH catheter |
|
|
182 | (1) |
|
Direct mucosal impedance measurement |
|
|
183 | (1) |
|
|
184 | (4) |
|
10 Ambulatory Monitoring for Reflux |
|
|
188 | (20) |
|
|
|
|
188 | (1) |
|
|
188 | (6) |
|
Catheter-based pH monitoring |
|
|
189 | (1) |
|
|
189 | (1) |
|
|
189 | (1) |
|
Interpretation: normal values |
|
|
190 | (1) |
|
|
190 | (1) |
|
|
191 | (1) |
|
|
191 | (1) |
|
Comparison between catheter and capsule |
|
|
192 | (1) |
|
Tolerability and complications |
|
|
192 | (1) |
|
Benefit of extended duration of recording |
|
|
192 | (1) |
|
Clinical relevance of esophageal pH monitoring |
|
|
192 | (1) |
|
pH monitoring off therapy |
|
|
192 | (1) |
|
|
193 | (1) |
|
Esophageal pH-impedance monitoring |
|
|
194 | (4) |
|
|
194 | (1) |
|
|
195 | (1) |
|
|
195 | (2) |
|
Clinical relevance of esophageal pH-impedance monitoring |
|
|
197 | (1) |
|
|
197 | (1) |
|
|
197 | (1) |
|
|
197 | (1) |
|
Esophageal bilirubin monitoring |
|
|
198 | (1) |
|
|
198 | (1) |
|
Clinical relevance of esophageal bilirubin monitoring |
|
|
198 | (1) |
|
Symptom association analysis |
|
|
199 | (1) |
|
|
200 | (1) |
|
|
200 | (1) |
|
|
201 | (1) |
|
Functional heartburn/chest pain or alternate diagnosis |
|
|
201 | (1) |
|
|
201 | (1) |
|
|
201 | (2) |
|
|
201 | (1) |
|
|
202 | (1) |
|
|
203 | (1) |
|
|
203 | (5) |
|
11 New Diagnostic Tests for GERD |
|
|
208 | (10) |
|
|
|
|
208 | (1) |
|
|
208 | (1) |
|
Novel impedance parameters |
|
|
209 | (1) |
|
|
210 | (1) |
|
|
211 | (1) |
|
Oropharyngeal pH monitoring |
|
|
212 | (2) |
|
|
214 | (1) |
|
|
214 | (1) |
|
|
214 | (4) |
|
12 Role of Histology and Cytology in Esophageal Diseases |
|
|
218 | (29) |
|
|
|
|
218 | (1) |
|
|
218 | (1) |
|
|
219 | (6) |
|
|
220 | (1) |
|
|
220 | (1) |
|
|
220 | (1) |
|
Cytomegalovirus esophagitis |
|
|
221 | (1) |
|
Other types of infectious esophagitis |
|
|
222 | (1) |
|
Radiation- and chemotherapy-induced esophagitis |
|
|
222 | (1) |
|
Pill/drug-induced and corrosive esophagitis |
|
|
223 | (1) |
|
Pill/drug-related esophagitis |
|
|
223 | (1) |
|
|
224 | (1) |
|
Primary eosinophilic esophagitis |
|
|
224 | (1) |
|
Primary lymphocytic esophagitis |
|
|
225 | (1) |
|
Esophageal Involvement in Systemic Disease |
|
|
225 | (1) |
|
Eosinophilic gastroenteritis |
|
|
225 | (1) |
|
|
226 | (1) |
|
Esophageal manifestations of dermatologic and collagen vascular diseases |
|
|
226 | (2) |
|
|
226 | (1) |
|
|
226 | (1) |
|
|
226 | (1) |
|
|
226 | (1) |
|
Collagen vascular diseases |
|
|
227 | (1) |
|
|
227 | (1) |
|
Graft-versus-host disease |
|
|
227 | (1) |
|
Gastroesophageal reflux esophagitis |
|
|
228 | (2) |
|
|
230 | (10) |
|
Diagnosis in esophageal mucosal biopsy |
|
|
230 | (2) |
|
Barrett's esophagus-related dysplasia and neoplasm |
|
|
232 | (1) |
|
Diagnosis in esophageal mucosal biopsies |
|
|
232 | (1) |
|
|
232 | (1) |
|
|
233 | (1) |
|
|
233 | (1) |
|
Intramucosal adenocarcinoma |
|
|
234 | (1) |
|
Adenocarcinoma with submucosal invasion |
|
|
234 | (1) |
|
|
235 | (1) |
|
Evaluation of endoscopic mucosal resection and endoscopic submucosal dissection specimens |
|
|
235 | (1) |
|
Evaluation of esophageal mucosal biopsy following mucosal ablation therapy |
|
|
235 | (1) |
|
Evaluation of esophageal cytology specimens in BE and BE-related neoplasia |
|
|
236 | (1) |
|
Other carcinomas and malignancies |
|
|
236 | (1) |
|
|
236 | (1) |
|
|
239 | (1) |
|
|
240 | (1) |
|
|
240 | (7) |
Part III Motility Disorders |
|
247 | (86) |
|
|
249 | (16) |
|
|
|
|
249 | (1) |
|
|
249 | (1) |
|
|
249 | (3) |
|
|
252 | (1) |
|
|
252 | (2) |
|
|
254 | (5) |
|
Pharmacological treatment |
|
|
254 | (1) |
|
|
254 | (1) |
|
|
254 | (1) |
|
|
255 | (1) |
|
Laparoscopic Heller myotomy |
|
|
256 | (1) |
|
Pneumodilation vs. laparoscopic Heller myotomy |
|
|
257 | (1) |
|
Per-oral endoscopic myotomy (POEM) |
|
|
258 | (1) |
|
What to do if symptoms reoccur following successful initial treatment |
|
|
259 | (1) |
|
Esophagectomy for end-stage achalasia |
|
|
259 | (1) |
|
|
259 | (1) |
|
To screen or not for esophageal cancer? |
|
|
260 | (1) |
|
|
260 | (1) |
|
|
261 | (4) |
|
14 Non-Achalasia Esophageal Motility Abnormalities |
|
|
265 | (13) |
|
|
|
265 | (1) |
|
Disorders with esophagogastric junction outflow obstruction other than achalasia |
|
|
265 | (2) |
|
Esophagogastric junction outflow obstruction |
|
|
265 | (2) |
|
Major disorders of peristalsis |
|
|
267 | (4) |
|
|
268 | (1) |
|
Hypercontractile peristalsis (jackhammer esophagus) |
|
|
269 | (1) |
|
Treatment of distal esophageal spasm and jackhammer esophagus |
|
|
270 | (1) |
|
Minor disorders of peristalsis |
|
|
271 | (2) |
|
Ineffective esophageal motility |
|
|
271 | (1) |
|
|
272 | (1) |
|
Treatment of ineffective esophageal motility and fragmented peristalsis |
|
|
272 | (1) |
|
Conclusions and future directions |
|
|
273 | (1) |
|
|
274 | (4) |
|
15 Surgery for Esophageal Motor Disorders: Achalasia, DES, Jackhammer, and EGJOO |
|
|
278 | (16) |
|
|
|
|
278 | (1) |
|
|
278 | (9) |
|
Endoscopic botulinum toxin injection |
|
|
279 | (1) |
|
|
279 | (1) |
|
Endoscopic pneumatic dilatation |
|
|
279 | (1) |
|
|
280 | (1) |
|
|
280 | (1) |
|
|
280 | (1) |
|
Per-oral endoscopic myotomy (POEM) |
|
|
280 | (1) |
|
|
281 | (1) |
|
|
281 | (1) |
|
|
281 | (1) |
|
|
281 | (1) |
|
|
282 | (1) |
|
|
282 | (1) |
|
POEM vs. pneumatic dilation |
|
|
283 | (1) |
|
Surgical esophageal myotomy |
|
|
283 | (1) |
|
|
283 | (1) |
|
|
284 | (1) |
|
|
285 | (1) |
|
Heller myotomy vs. pneumatic dilation |
|
|
286 | (1) |
|
Minimally invasive esophagectomy |
|
|
287 | (1) |
|
|
287 | (1) |
|
Esophagogastric junction outflow obstruction |
|
|
287 | (1) |
|
|
288 | (1) |
|
|
289 | (1) |
|
|
289 | (1) |
|
|
290 | (4) |
|
16 Esophageal Webs and Rings |
|
|
294 | (10) |
|
|
|
|
294 | (1) |
|
|
294 | (2) |
|
|
294 | (1) |
|
|
295 | (1) |
|
|
295 | (1) |
|
|
296 | (1) |
|
|
297 | (1) |
|
|
298 | (2) |
|
Epidemiology, pathology, and pathogenesis |
|
|
298 | (1) |
|
Presentation and diagnosis |
|
|
298 | (1) |
|
|
299 | (1) |
|
|
300 | (4) |
|
17 Esophageal Diverticula |
|
|
304 | (8) |
|
|
|
|
|
304 | (1) |
|
|
304 | (1) |
|
|
304 | (1) |
|
Proximal esophageal diverticula |
|
|
304 | (1) |
|
Mid-esophageal diverticula |
|
|
304 | (1) |
|
Lower esophageal diverticula (epiphrenic) |
|
|
304 | (1) |
|
|
305 | (1) |
|
|
305 | (1) |
|
|
306 | (1) |
|
|
306 | (1) |
|
|
306 | (1) |
|
|
306 | (1) |
|
Esophagogastroduodenoscopy (EGD) |
|
|
307 | (1) |
|
|
307 | (1) |
|
|
307 | (1) |
|
|
307 | (3) |
|
Cricopharyngeal diverticulum |
|
|
307 | (2) |
|
Mid-esophageal diverticulum |
|
|
309 | (1) |
|
|
309 | (1) |
|
Post-operative management |
|
|
310 | (1) |
|
|
311 | (1) |
|
18 Esophageal Involvement in Systemic Diseases |
|
|
312 | (21) |
|
|
|
312 | (1) |
|
Connective tissue disorders |
|
|
312 | (6) |
|
Systemic sclerosis (scleroderma) |
|
|
312 | (4) |
|
Mixed connective tissue disease |
|
|
316 | (1) |
|
|
316 | (1) |
|
|
317 | (1) |
|
Systemic lupus erythematosus |
|
|
318 | (1) |
|
|
318 | (1) |
|
|
318 | (1) |
|
|
318 | (1) |
|
|
319 | (1) |
|
|
319 | (1) |
|
|
319 | (1) |
|
|
320 | (1) |
|
|
320 | (2) |
|
|
320 | (2) |
|
|
322 | (1) |
|
|
322 | (2) |
|
|
322 | (1) |
|
|
323 | (1) |
|
|
323 | (1) |
|
|
324 | (1) |
|
|
324 | (1) |
|
|
324 | (1) |
|
|
325 | (1) |
|
|
325 | (1) |
|
|
325 | (8) |
Part IV Gastroesophageal Reflux Disease |
|
333 | (300) |
|
19 Clinical Spectrum and Diagnosis of GERD Phenotypes |
|
|
335 | (12) |
|
|
|
335 | (1) |
|
The current paradigm of gastroesophageal reflux disease |
|
|
335 | (1) |
|
Definition and prevalence |
|
|
335 | (1) |
|
The era of proton pump inhibitor therapy |
|
|
335 | (1) |
|
Clinical spectrum of GERD |
|
|
336 | (5) |
|
|
336 | (1) |
|
Esophageal syndromes of GERD |
|
|
337 | (1) |
|
Extraesophageal syndromes of GERD |
|
|
337 | (1) |
|
Clinical assessment for relevant comorbid conditions |
|
|
338 | (1) |
|
Clinical history: phenotypes |
|
|
338 | (1) |
|
|
338 | (1) |
|
Endoscopic assessment of esophageal mucosa |
|
|
338 | (1) |
|
Endoscopic assessment of the anti-reflux barrier |
|
|
339 | (1) |
|
Other roles of endoscopic assessment in GERD |
|
|
339 | (1) |
|
Upper gastrointestinal endoscopy: phenotypes |
|
|
339 | (1) |
|
Ambulatory reflux monitoring |
|
|
339 | (1) |
|
Ambulatory reflux monitoring systems |
|
|
340 | (1) |
|
Ambulatory reflux monitoring with or without acid suppression |
|
|
340 | (1) |
|
Ambulatory reflux monitoring metrics |
|
|
340 | (1) |
|
Correlation between symptoms and ambulatory reflux events |
|
|
341 | (1) |
|
|
341 | (1) |
|
Ambulatory reflux monitoring: phenotypes |
|
|
341 | (1) |
|
Stepwise framework to phenotyping across the GERD spectrum |
|
|
341 | (1) |
|
Further esophageal physiologic testing |
|
|
341 | (2) |
|
|
341 | (1) |
|
Ambulatory reflux monitoring on acid suppression |
|
|
342 | (1) |
|
|
343 | (1) |
|
|
343 | (4) |
|
20 Hiatus Hernia and Gastroesophageal Reflux Disease |
|
|
347 | (11) |
|
|
|
|
347 | (1) |
|
Anatomy of the diaphragm and the esophagogastric junction |
|
|
347 | (1) |
|
Physiology of the esophagogastric junction |
|
|
348 | (1) |
|
|
349 | (1) |
|
|
349 | (1) |
|
Type II and III hiatus hernias |
|
|
350 | (1) |
|
|
350 | (1) |
|
Congenital diaphragmatic hernias |
|
|
350 | (1) |
|
Sliding hiatus hernia and reflux disease |
|
|
350 | (2) |
|
|
352 | (1) |
|
|
353 | (1) |
|
|
354 | (1) |
|
|
354 | (4) |
|
21 Pathophysiology of Gastroesophageal Reflux Disease: Motility Factors |
|
|
358 | (18) |
|
|
|
|
358 | (1) |
|
Sphincter mechanism at the esophagogastric junction (EGJ) |
|
|
358 | (2) |
|
|
358 | (1) |
|
Morphology of the sphincter mechanism at the esophagogastric Junction (EGJ) |
|
|
358 | (2) |
|
Gastroesophageal junction pressure under various physiologic conditions |
|
|
360 | (3) |
|
Circumferential and axial asymmetry of the EGJ pressure |
|
|
361 | (1) |
|
Neural control of the lower esophageal sphincter and crural diaphragm |
|
|
362 | (1) |
|
Physiologic significance of the two lower esophageal sphincters at the EGJ |
|
|
363 | (1) |
|
Mechanisms of gastroesophageal reflux |
|
|
363 | (5) |
|
Transient lower esophageal sphincter relaxation (TLESR) |
|
|
363 | (1) |
|
Characteristics of transient lower esophageal sphincter relaxation (TLESR) |
|
|
364 | (1) |
|
Stimuli that trigger transient lower esophageal sphincter relaxations |
|
|
365 | (1) |
|
|
365 | (1) |
|
|
365 | (1) |
|
Factors modulating the rate of transient lower esophageal sphincter relaxations |
|
|
366 | (1) |
|
Neural pathways mediating transient lower esophageal sphincter relaxation: vagal control mechanisms |
|
|
366 | (1) |
|
Effect of antireflux therapy on transient lower esophageal sphincter relaxation |
|
|
368 | (1) |
|
Lower esophageal sphincter hypotension in reflux disease |
|
|
368 | (1) |
|
Hiatus hernia and reflux disease |
|
|
368 | (1) |
|
Compliance/opening function of LES and EGJ in GER disease |
|
|
369 | (1) |
|
Role of esophageal peristalsis in reflux disease |
|
|
370 | (1) |
|
|
370 | (1) |
|
|
371 | (5) |
|
22 Pathophysiology of Gastroesophageal Reflux Disease: Epithelial Factors |
|
|
376 | (18) |
|
|
|
|
376 | (1) |
|
Acid, pepsin, and bile acids: the epithelial triple threat |
|
|
376 | (1) |
|
Development of the esophagus and its defensive players |
|
|
377 | (1) |
|
Esophageal tissue resistance: epithelial factors and beyond |
|
|
378 | (4) |
|
|
378 | (1) |
|
|
378 | (3) |
|
|
381 | (1) |
|
Assessing the epithelial barrier: measurements of resistance, permeability, and intercellular spaces |
|
|
382 | (1) |
|
Pathophysiology of GERD and reflux esophagitis: acid burn or cytokine sizzle? |
|
|
382 | (6) |
|
Acid burn: the traditional concept |
|
|
382 | (1) |
|
Pathogenesis of GERD and acute reflux esophagitis: lessons from the rabbit model and GERD patients |
|
|
382 | (2) |
|
Cytokine sizzle: the alternative concept |
|
|
384 | (1) |
|
Pathogenesis of GERD and acute reflux esophagitis: lessons from the rat model and from GERD patients |
|
|
384 | (1) |
|
Pathogenesis of GERD and acute reflux esophagitis: lessons from the human model |
|
|
385 | (1) |
|
Hypoxia-inducible factor-2a: a key mediator of the cytokine sizzle in human reflux esophagitis |
|
|
387 | (1) |
|
Conclusions and future directions |
|
|
388 | (1) |
|
|
388 | (6) |
|
23 Duodenogastroesophageal Reflux |
|
|
394 | (25) |
|
|
|
|
394 | (1) |
|
The role of acid and pepsin |
|
|
394 | (2) |
|
|
394 | (1) |
|
|
395 | (1) |
|
The role of duodenal contents |
|
|
396 | (5) |
|
Bile acids in the pathogenesis of Barrett's esophagus and/or esophageal adenocarcinoma |
|
|
396 | (2) |
|
|
398 | (2) |
|
Bile acids in the pathogenesis of erosive and non-erosive reflux disease |
|
|
400 | (1) |
|
Impact of DGER on laryngeal and respiratory mucosa |
|
|
401 | (1) |
|
Detection of DGER in humans |
|
|
402 | (8) |
|
|
402 | (1) |
|
|
402 | (1) |
|
|
402 | (1) |
|
|
403 | (1) |
|
|
403 | (1) |
|
|
403 | (1) |
|
|
404 | (1) |
|
Ambulatory bilirubin monitoring (Bilitec) |
|
|
405 | (3) |
|
|
408 | (1) |
|
|
409 | (1) |
|
DGER and bariatric surgery |
|
|
410 | (1) |
|
Medical and surgical treatment |
|
|
410 | (2) |
|
|
412 | (1) |
|
|
413 | (6) |
|
24 Helicobacter pylori and GERD |
|
|
419 | (9) |
|
|
|
|
419 | (1) |
|
Epidemiology of H. pylori and GERD |
|
|
419 | (1) |
|
Pathobiology of H. pylori and GERD |
|
|
419 | (2) |
|
Implication of eradication of H. pylori on de novo GERD |
|
|
421 | (1) |
|
Implication of H. pylori eradication on patients with known GERD |
|
|
422 | (1) |
|
H. pylori and Barrett's esophagus |
|
|
422 | (1) |
|
H. pylori and esophageal adenocarcinoma and gastroesophageal junction adenocarcinoma |
|
|
422 | (1) |
|
Professional guidelines, recommendations, and updates |
|
|
423 | (1) |
|
|
423 | (1) |
|
|
424 | (4) |
|
25 Medical Management of Gastroesophageal Reflux Disease |
|
|
428 | (16) |
|
|
|
|
428 | (1) |
|
|
428 | (3) |
|
|
429 | (1) |
|
|
430 | (1) |
|
|
430 | (1) |
|
|
430 | (1) |
|
|
431 | (5) |
|
|
431 | (1) |
|
|
431 | (1) |
|
|
431 | (1) |
|
|
432 | (1) |
|
|
432 | (1) |
|
|
432 | (1) |
|
|
433 | (1) |
|
Proton pump inhibitors (PPIs) |
|
|
433 | (1) |
|
|
434 | (1) |
|
|
434 | (1) |
|
|
434 | (1) |
|
Healing of erosive esophagitis |
|
|
434 | (1) |
|
|
434 | (2) |
|
|
436 | (3) |
|
|
436 | (1) |
|
|
437 | (2) |
|
Newer antisecretory agents: potassium-competitive acid blockers |
|
|
439 | (1) |
|
|
439 | (5) |
|
26 Refractory Heartburn: Reflux Hypersensitivity and Functional Heartburn |
|
|
444 | (21) |
|
|
|
|
444 | (1) |
|
|
445 | (8) |
|
|
445 | (1) |
|
|
446 | (1) |
|
|
447 | (3) |
|
|
450 | (1) |
|
|
450 | (1) |
|
|
451 | (2) |
|
|
453 | (5) |
|
|
454 | (1) |
|
|
454 | (1) |
|
|
455 | (1) |
|
|
456 | (1) |
|
|
456 | (1) |
|
|
457 | (1) |
|
|
458 | (1) |
|
|
459 | (6) |
|
27 Endoscopic Therapies for GERD |
|
|
465 | (27) |
|
|
|
465 | (1) |
|
Understanding GEJ anatomy and physiology |
|
|
466 | (1) |
|
Radiofrequency energy treatment of GERD (Stretta) |
|
|
467 | (7) |
|
Stretta mechanisms of action |
|
|
467 | (1) |
|
Stretta patient selection |
|
|
468 | (1) |
|
Stretta in altered anatomy |
|
|
468 | (1) |
|
Stretta technical considerations |
|
|
469 | (2) |
|
Stretta safety and clinical outcomes |
|
|
471 | (3) |
|
|
474 | (1) |
|
Trans-oral incisionless fundoplication (TIF) |
|
|
474 | (9) |
|
|
474 | (2) |
|
|
476 | (1) |
|
TIF technical considerations |
|
|
476 | (3) |
|
TIF safety and clinical outcomes |
|
|
479 | (2) |
|
Concomitant laparoscopic hernia repair and TIF |
|
|
481 | (1) |
|
Emerging applications for TIF |
|
|
482 | (1) |
|
|
483 | (1) |
|
Endoscopic suturing for GERD |
|
|
483 | (4) |
|
Gastro-gastric plication mechanism of action |
|
|
484 | (1) |
|
Evolution of full-thickness endoscopic suturing for GERD |
|
|
484 | (3) |
|
|
487 | (1) |
|
|
487 | (5) |
|
28 Behavioral Treatment of Oropharyngeal and Esophageal Disorders |
|
|
492 | (18) |
|
|
|
492 | (6) |
|
|
492 | (1) |
|
Oropharyngeal swallow assessment |
|
|
493 | (1) |
|
Multiphase swallow assessment |
|
|
493 | (2) |
|
Dysphagia rehabilitation principles |
|
|
495 | (1) |
|
Indirect swallowing treatment |
|
|
495 | (1) |
|
|
495 | (1) |
|
|
496 | (1) |
|
|
496 | (1) |
|
|
496 | (1) |
|
Direct swallowing treatment |
|
|
497 | (1) |
|
|
497 | (1) |
|
Pharyngeal phase exercise |
|
|
497 | (1) |
|
Behavioral strategies for esophageal dysphagia |
|
|
498 | (1) |
|
|
498 | (2) |
|
|
499 | (1) |
|
Behavioral treatment of aerophagia |
|
|
499 | (1) |
|
|
500 | (1) |
|
Assessment of supragastric belching |
|
|
500 | (1) |
|
Behavioral treatment of supragastric belching |
|
|
500 | (1) |
|
Plan of care for supragastric belching |
|
|
500 | (1) |
|
|
501 | (1) |
|
|
501 | (1) |
|
Behavioral treatment of rumination |
|
|
501 | (1) |
|
Plan of care for rumination |
|
|
502 | (1) |
|
|
502 | (1) |
|
|
502 | (1) |
|
|
502 | (1) |
|
|
502 | (1) |
|
Disorders of laryngeal hyper-responsiveness |
|
|
503 | (2) |
|
|
503 | (1) |
|
Plan of care for behavioral treatment of VCD |
|
|
504 | (1) |
|
|
504 | (1) |
|
Plan of care for behavioral treatment of chronic cough |
|
|
505 | (1) |
|
|
505 | (1) |
|
|
505 | (5) |
|
|
510 | (22) |
|
|
|
|
510 | (1) |
|
Definition and diagnostic criteria |
|
|
510 | (1) |
|
|
511 | (1) |
|
Pathogenesis and progression |
|
|
511 | (4) |
|
Pathogenesis of metaplasia |
|
|
511 | (2) |
|
The neoplastic progression |
|
|
513 | (1) |
|
|
514 | (1) |
|
|
515 | (1) |
|
|
515 | (1) |
|
|
515 | (1) |
|
|
516 | (3) |
|
|
516 | (1) |
|
|
516 | (1) |
|
Advanced imaging techniques |
|
|
517 | (1) |
|
|
517 | (1) |
|
Narrow-band imaging (electronic chromoendoscopy) |
|
|
518 | (1) |
|
Confocal laser endomicroscopy |
|
|
518 | (1) |
|
Additional enhanced imaging techniques |
|
|
519 | (1) |
|
|
519 | (4) |
|
|
519 | (1) |
|
|
519 | (1) |
|
|
520 | (1) |
|
Chemopreventive agents and the AspECT trial |
|
|
520 | (1) |
|
Treatment of dysplastic Barrett's esophagus |
|
|
521 | (1) |
|
Endoscopic eradication therapy |
|
|
521 | (1) |
|
Endoscopic mucosal resection |
|
|
521 | (1) |
|
Endoscopic submucosal dissection (ESD) |
|
|
522 | (1) |
|
Endoscopic ablative techniques |
|
|
522 | (1) |
|
|
522 | (1) |
|
|
523 | (1) |
|
Argon plasma coagulation (APC) |
|
|
523 | (1) |
|
|
523 | (2) |
|
|
523 | (1) |
|
|
524 | (1) |
|
|
525 | (7) |
|
|
532 | (22) |
|
|
|
Classification of strictures |
|
|
532 | (1) |
|
Types of esophageal dilators |
|
|
533 | (1) |
|
Techniques of esophageal dilation |
|
|
534 | (3) |
|
Choosing the correct initial dilator size |
|
|
534 | (1) |
|
|
534 | (1) |
|
Selection of dilators and need for fluoroscopy |
|
|
535 | (1) |
|
|
535 | (1) |
|
|
535 | (1) |
|
Other tips for esophageal dilation |
|
|
536 | (1) |
|
Complications of esophageal dilation |
|
|
536 | (1) |
|
|
537 | (4) |
|
|
537 | (1) |
|
|
538 | (1) |
|
|
539 | (1) |
|
|
539 | (1) |
|
|
539 | (1) |
|
|
540 | (1) |
|
|
541 | (2) |
|
Post-endoscopic therapy strictures |
|
|
541 | (1) |
|
|
541 | (1) |
|
Post-operative strictures |
|
|
542 | (1) |
|
Radiation-induced strictures |
|
|
543 | (1) |
|
|
543 | (1) |
|
Nasogastric tube strictures |
|
|
544 | (1) |
|
|
544 | (1) |
|
|
544 | (1) |
|
|
545 | (1) |
|
|
545 | (1) |
|
|
546 | (1) |
|
|
547 | (1) |
|
|
547 | (1) |
|
|
548 | (6) |
|
31 ENT Complaints in GERD |
|
|
554 | (13) |
|
|
|
|
|
554 | (1) |
|
|
555 | (1) |
|
|
555 | (1) |
|
|
555 | (2) |
|
|
557 | (2) |
|
Confirmatory testing for EER/LPR |
|
|
559 | (2) |
|
|
561 | (1) |
|
|
561 | (1) |
|
|
562 | (1) |
|
|
563 | (1) |
|
|
563 | (1) |
|
|
563 | (4) |
|
32 Pulmonary Complications of Gastroesophageal Reflux Disease |
|
|
567 | (14) |
|
|
|
567 | (1) |
|
|
567 | (2) |
|
Clinical presentations and evaluation |
|
|
569 | (1) |
|
|
570 | (1) |
|
|
570 | (3) |
|
|
571 | (1) |
|
Reflux monitoring in asthma |
|
|
571 | (1) |
|
Antireflux surgery in asthma |
|
|
572 | (1) |
|
Pulmonary fibrosis and GERD |
|
|
573 | (2) |
|
|
573 | (1) |
|
Antireflux therapies in IPF |
|
|
574 | (1) |
|
|
575 | (2) |
|
Reflux testing and lung transplantation |
|
|
575 | (1) |
|
Antireflux therapy in lung transplantation |
|
|
576 | (1) |
|
|
577 | (1) |
|
|
577 | (4) |
|
33 Pediatric Gastroesophageal Reflux Disease |
|
|
581 | (10) |
|
|
|
|
581 | (1) |
|
|
581 | (1) |
|
|
581 | (1) |
|
|
582 | (1) |
|
|
582 | (2) |
|
Upper gastrointestinal radiography (UGI) |
|
|
582 | (1) |
|
|
582 | (1) |
|
|
583 | (1) |
|
|
583 | (1) |
|
Multichannel intraluminal impedance with pH (pH-MH) |
|
|
583 | (1) |
|
|
583 | (1) |
|
Upper endoscopy with biopsy of the esophagus |
|
|
584 | (1) |
|
Other diagnostic approaches |
|
|
584 | (1) |
|
|
584 | (2) |
|
Non-pharmacologic therapies |
|
|
584 | (2) |
|
|
586 | (1) |
|
|
586 | (1) |
|
|
586 | (1) |
|
|
587 | (1) |
|
|
587 | (1) |
|
|
588 | (1) |
|
|
588 | (3) |
|
34 Challenges in the Understanding and Application of Antireflux Surgery for GERD |
|
|
591 | (11) |
|
|
|
|
591 | (1) |
|
|
591 | (5) |
|
|
592 | (1) |
|
Post-fundoplication side effects |
|
|
593 | (1) |
|
Candidates for antireflux surgery |
|
|
594 | (1) |
|
Application of surgical therapy to patients with GERD |
|
|
595 | (1) |
|
Outcome with a fundoplication |
|
|
595 | (1) |
|
Longevity of antireflux surgery |
|
|
596 | (1) |
|
Antireflux surgery and Barrett's esophagus |
|
|
597 | (1) |
|
Impact of antireflux surgery on the development of intestinal metaplasia |
|
|
597 | (1) |
|
Impact of antireflux surgery on intestinal metaplasia already present prior to surgery |
|
|
597 | (1) |
|
Impact of antireflux surgery on low-grade dysplasia |
|
|
598 | (1) |
|
Impact of antireflux surgery on progression of Barrett's and development of esophageal adenocarcinoma |
|
|
598 | (1) |
|
Antireflux surgery in patients with Barrett's: word of caution |
|
|
598 | (1) |
|
|
598 | (1) |
|
|
599 | (3) |
|
35 New Surgical Treatments for GERD |
|
|
602 | (22) |
|
|
|
602 | (1) |
|
The importance of alternatives therapies |
|
|
602 | (1) |
|
Limitations of Nissen fundoplication |
|
|
602 | (1) |
|
Magnetic sphincter augmentation (MSA) of the lower esophageal sphincter |
|
|
603 | (7) |
|
|
603 | (1) |
|
Initial design considerations |
|
|
603 | (1) |
|
LES length as a reflux barrier |
|
|
605 | (1) |
|
Physiologic comparison to fundoplication |
|
|
605 | (1) |
|
Design safety considerations |
|
|
605 | (1) |
|
Initial surgical technique and results |
|
|
605 | (1) |
|
|
606 | (1) |
|
The essential role of the crural diaphragmatic sphincter |
|
|
606 | (1) |
|
Crural repair and evolution of surgical technique |
|
|
606 | (1) |
|
Evolving concept of LINX sizing |
|
|
607 | (1) |
|
Current MSA technique with restoration of the crural sphincter |
|
|
608 | (2) |
|
Current approach to patient selection and perioperative management |
|
|
610 | (1) |
|
Patient selection and preoperative evaluation |
|
|
610 | (1) |
|
Surgical training expertise |
|
|
611 | (1) |
|
|
611 | (1) |
|
|
611 | (1) |
|
Patient-reported outcomes |
|
|
611 | (1) |
|
|
613 | (1) |
|
|
613 | (1) |
|
|
614 | (1) |
|
|
614 | (1) |
|
Comparison to fundoplication |
|
|
614 | (1) |
|
Specific presenting symptoms |
|
|
615 | (1) |
|
Predictors of outcomes of MSA |
|
|
616 | (1) |
|
|
616 | (1) |
|
|
616 | (1) |
|
|
616 | (1) |
|
|
616 | (1) |
|
Comparison to other implants |
|
|
616 | (1) |
|
|
616 | (1) |
|
Other device limitations and concerns |
|
|
617 | (1) |
|
Risks, side effects, and complications |
|
|
618 | (1) |
|
|
618 | (1) |
|
|
618 | (1) |
|
Reoperation after MSA implantation |
|
|
618 | (1) |
|
|
619 | (1) |
|
Magnetic sphincter augmentation - conclusions |
|
|
619 | (1) |
|
Lower esophageal sphincter (LES) electrical neuromodulation therapy (LES-ENT) |
|
|
619 | (1) |
|
|
620 | (4) |
|
36 Obesity and Gastroesophageal Reflux Disease |
|
|
624 | (9) |
|
|
|
|
624 | (1) |
|
Obesity and GERD symptoms |
|
|
625 | (1) |
|
Obesity and GERD-related complications |
|
|
625 | (1) |
|
Mechanical and non-mechanical effects of obesity |
|
|
626 | (2) |
|
Mechanical effects of obesity on the gastroesophageal junction |
|
|
626 | (2) |
|
Non-mechanical effects of obesity |
|
|
628 | (1) |
|
Weight loss as GERD treatment |
|
|
628 | (1) |
|
|
629 | (4) |
Part V Malignant Disease |
|
633 | (46) |
|
37 Tumors of the Esophagus |
|
|
635 | (16) |
|
|
|
|
635 | (1) |
|
Malignant esophageal cancers |
|
|
635 | (7) |
|
|
635 | (1) |
|
|
635 | (2) |
|
Clinical presentation and diagnosis |
|
|
637 | (1) |
|
Staging of esophageal cancer |
|
|
637 | (2) |
|
Restaging after initial chemoradiotherapy |
|
|
639 | (1) |
|
Endoscopic treatment of esophageal cancer |
|
|
640 | (1) |
|
Palliation of unresectable esophageal cancer |
|
|
641 | (1) |
|
Other malignancies of the esophagus |
|
|
642 | (1) |
|
|
642 | (1) |
|
Benign tumors of the esophagus |
|
|
642 | (2) |
|
|
642 | (1) |
|
|
643 | (1) |
|
|
643 | (1) |
|
|
643 | (1) |
|
Other benign esophageal lesions |
|
|
644 | (1) |
|
|
644 | (1) |
|
|
644 | (7) |
|
38 Endoscopic Treatment of Esophageal Cancer |
|
|
651 | (10) |
|
|
|
Rationale for the endoscopic treatment of esophageal cancer |
|
|
651 | (1) |
|
Methods used in the endoscopic treatment of esophageal carcinoma |
|
|
652 | (4) |
|
|
656 | (1) |
|
Ablation of residual Barrett's esophagus after resection of focal adenocarcinoma lesions |
|
|
656 | (1) |
|
Endoscopic ablation of non-resectable EAC |
|
|
656 | (1) |
|
Adjuvant chemotherapy and radiation therapy |
|
|
656 | (1) |
|
Outcomes of endoscopic treatment of early esophageal cancer |
|
|
656 | (2) |
|
T1a (mucosal) adenocarcinoma |
|
|
656 | (2) |
|
T1b (submucosal) adenocarcinoma |
|
|
658 | (1) |
|
|
658 | (3) |
|
39 Surgical Treatment for Esophageal Cancer |
|
|
661 | (18) |
|
|
|
|
661 | (1) |
|
|
661 | (1) |
|
|
661 | (2) |
|
|
663 | (1) |
|
|
663 | (1) |
|
|
663 | (1) |
|
Preoperative assessment of physiological status |
|
|
663 | (2) |
|
|
664 | (1) |
|
|
665 | (1) |
|
|
665 | (1) |
|
Preoperative composite risk score and nomograms |
|
|
665 | (1) |
|
|
665 | (4) |
|
Resection of primary tumor |
|
|
665 | (1) |
|
|
666 | (1) |
|
|
666 | (1) |
|
|
667 | (1) |
|
|
667 | (1) |
|
|
668 | (1) |
|
|
669 | (1) |
|
|
669 | (1) |
|
|
669 | (1) |
|
Pragmatic therapeutic strategy |
|
|
670 | (1) |
|
|
671 | (1) |
|
|
672 | (1) |
|
|
672 | (7) |
Part VI Miscellaneous |
|
679 | |
|
40 Eosinophilic Esophagitis |
|
|
681 | (32) |
|
|
|
|
681 | (1) |
|
|
681 | (1) |
|
|
681 | (2) |
|
|
682 | (1) |
|
|
682 | (1) |
|
|
683 | (3) |
|
Current diagnostic criteria and approach |
|
|
684 | (1) |
|
Disease activity measures |
|
|
685 | (1) |
|
|
686 | (4) |
|
|
686 | (1) |
|
|
686 | (2) |
|
Endoluminal ultrasonography |
|
|
688 | (1) |
|
|
688 | (1) |
|
|
689 | (1) |
|
|
689 | (1) |
|
|
690 | (1) |
|
|
691 | (1) |
|
|
692 | (1) |
|
|
693 | (8) |
|
|
693 | (1) |
|
|
694 | (1) |
|
|
695 | (1) |
|
Swallowed topical corticosteroids |
|
|
696 | (1) |
|
|
697 | (1) |
|
|
697 | (1) |
|
|
698 | (1) |
|
|
698 | (1) |
|
|
699 | (1) |
|
|
699 | (1) |
|
|
699 | (1) |
|
|
700 | (1) |
|
|
701 | (1) |
|
|
701 | (12) |
|
|
713 | (15) |
|
|
|
713 | (1) |
|
Anatomical considerations |
|
|
714 | (3) |
|
|
717 | (1) |
|
|
718 | (1) |
|
|
719 | (2) |
|
|
719 | (1) |
|
|
719 | (1) |
|
|
719 | (1) |
|
|
720 | (1) |
|
|
721 | (2) |
|
|
723 | (1) |
|
|
723 | (1) |
|
|
724 | (1) |
|
Small, blunt, round objects |
|
|
725 | (1) |
|
|
725 | (1) |
|
|
725 | (1) |
|
Dishwasher or laundry pods |
|
|
725 | (1) |
|
|
726 | (1) |
|
Management of complications |
|
|
726 | (1) |
|
|
726 | (2) |
|
42 Medication-Induced Esophageal, Injury |
|
|
728 | (8) |
|
|
|
728 | (1) |
|
|
728 | (1) |
|
|
729 | (1) |
|
Clinical features and diagnosis |
|
|
729 | (1) |
|
Prevention, treatment, and clinical course |
|
|
729 | (1) |
|
|
730 | (2) |
|
|
730 | (1) |
|
|
730 | (1) |
|
|
731 | (1) |
|
Other medications commonly associated with pill-induced injury |
|
|
731 | (1) |
|
Chemotherapy-induced esophagitis |
|
|
732 | (1) |
|
|
732 | (4) |
|
43 Esophagitis in the Immunocompromised Host |
|
|
736 | (21) |
|
|
|
|
736 | (1) |
|
|
736 | (1) |
|
|
737 | (1) |
|
|
737 | (1) |
|
|
738 | (6) |
|
|
738 | (1) |
|
|
738 | (1) |
|
|
738 | (1) |
|
|
739 | (1) |
|
|
739 | (1) |
|
|
739 | (1) |
|
|
740 | (1) |
|
|
742 | (1) |
|
|
742 | (1) |
|
|
743 | (1) |
|
|
743 | (1) |
|
Pathology, clinical manifestations, and complications |
|
|
743 | (1) |
|
|
743 | (1) |
|
|
743 | (1) |
|
|
744 | (4) |
|
|
744 | (1) |
|
|
744 | (1) |
|
|
744 | (1) |
|
Clinical manifestations and complications |
|
|
744 | (1) |
|
|
745 | (1) |
|
|
745 | (1) |
|
|
745 | (1) |
|
|
745 | (1) |
|
|
745 | (1) |
|
Clinical manifestations and complications |
|
|
746 | (1) |
|
|
746 | (1) |
|
|
746 | (1) |
|
|
747 | (1) |
|
|
747 | (1) |
|
|
748 | (1) |
|
|
748 | (1) |
|
|
748 | (1) |
|
Clinical manifestations and complications |
|
|
748 | (1) |
|
|
748 | (1) |
|
|
748 | (1) |
|
|
748 | (1) |
|
|
748 | (1) |
|
|
749 | (1) |
|
Clinical manifestations and complications |
|
|
749 | (1) |
|
|
749 | (1) |
|
|
749 | (1) |
|
|
749 | (1) |
|
|
749 | (1) |
|
Selected HIV-related esophageal disorders |
|
|
749 | (2) |
|
Disorders associated with primary HIV- infection |
|
|
750 | (1) |
|
Idiopathic esophageal ulcer |
|
|
750 | (1) |
|
|
750 | (1) |
|
|
750 | (1) |
|
Clinical manifestations and complications |
|
|
750 | (1) |
|
|
750 | (1) |
|
|
750 | (1) |
|
|
751 | (6) |
|
44 Caustic Injuries of the Esophagus |
|
|
757 | (12) |
|
|
|
757 | (1) |
|
|
757 | (1) |
|
|
757 | (1) |
|
|
757 | (1) |
|
|
758 | (1) |
|
|
759 | (1) |
|
Risks of specific substances |
|
|
759 | (1) |
|
|
759 | (1) |
|
|
760 | (2) |
|
|
760 | (1) |
|
|
760 | (2) |
|
|
762 | (1) |
|
Stabilization and supportive care |
|
|
762 | (1) |
|
No role for emetics, neutralizing agents, or corticosteroids |
|
|
762 | (1) |
|
|
762 | (1) |
|
|
763 | (1) |
|
Management of late complications |
|
|
763 | (1) |
|
|
763 | (1) |
|
Intralesional steroid injection |
|
|
763 | (1) |
|
|
764 | (1) |
|
|
764 | (1) |
|
|
764 | (1) |
|
|
764 | (1) |
|
|
764 | (5) |
|
45 Rupture and Perforation of the Esophagus |
|
|
769 | (20) |
|
|
|
|
769 | (1) |
|
|
769 | (1) |
|
|
769 | (2) |
|
|
771 | (1) |
|
|
771 | (1) |
|
|
772 | (1) |
|
|
772 | (1) |
|
Clinical features and diagnosis |
|
|
773 | (1) |
|
|
773 | (1) |
|
|
773 | (1) |
|
|
774 | (1) |
|
|
774 | (1) |
|
|
775 | (1) |
|
|
776 | (7) |
|
|
777 | (3) |
|
|
780 | (1) |
|
Alternative endoscopic methods |
|
|
781 | (2) |
|
|
783 | (1) |
|
|
783 | (1) |
|
|
783 | (6) |
|
46 Cutaneous Diseases of the Esophagus |
|
|
789 | (15) |
|
|
|
789 | (1) |
|
Inflammatory mucocutaneous disorders of the skin and mucous membranes including the esophagus |
|
|
789 | (7) |
|
Autoimmune mucocutaneous blistering disorders |
|
|
789 | (1) |
|
Mucous membrane pemphigoid |
|
|
789 | (1) |
|
Epidermolysis bullosa acquisita |
|
|
791 | (1) |
|
Bullous systemic lupus erythematosus |
|
|
792 | (1) |
|
|
792 | (1) |
|
Paraneoplastic autoimmune multiorgan syndrome (paraneoplastic pemphigus) |
|
|
793 | (1) |
|
|
793 | (1) |
|
Stevens Johnson syndrome and toxic epidermal necrolysis |
|
|
795 | (1) |
|
Multisystem disorders that have both mucocutaneous and esophageal manifestations |
|
|
796 | (3) |
|
Autoimmune connective tissue disorders |
|
|
796 | (1) |
|
|
796 | (1) |
|
|
797 | (1) |
|
Systemic lupus erythematosus |
|
|
797 | (1) |
|
Mixed connective tissue disease |
|
|
797 | (1) |
|
|
798 | (1) |
|
Cutaneous paraneoplastic disorders associated with esophageal carcinoma |
|
|
798 | (1) |
|
|
798 | (1) |
|
Tylosis with esophageal cancer |
|
|
798 | (1) |
|
Plummer-Vinson-Patterson-Kelly syndrome |
|
|
798 | (1) |
|
|
798 | (1) |
|
Other cutaneous paraneoplastic disorders |
|
|
798 | (1) |
|
Genodermatoses with esophageal manifestations |
|
|
799 | (1) |
|
|
799 | (5) |
|
47 Esophageal Disease in Older Patients |
|
|
804 | |
|
|
|
|
804 | (1) |
|
Changes in esophageal physiology with aging |
|
|
805 | (4) |
|
|
805 | (1) |
|
Upper esophageal sphincter/pharynx |
|
|
805 | (1) |
|
|
805 | (1) |
|
Lower esophageal sphincter |
|
|
806 | (2) |
|
|
808 | (1) |
|
Gastroesophageal reflux disease in older patients |
|
|
808 | (1) |
|
Changes in gastroesophageal reflux disease-related physiology with aging |
|
|
809 | (2) |
|
Role of Helicobacter pylori infection and other gastric factors |
|
|
809 | (1) |
|
|
810 | (1) |
|
Differences in presentation |
|
|
810 | (1) |
|
|
810 | (1) |
|
Special considerations related to Barrett's esophagus in older patients |
|
|
810 | (1) |
|
Differences in treatment of older patients |
|
|
811 | (2) |
|
Lifestyle and patient-directed therapy |
|
|
811 | (1) |
|
|
811 | (2) |
|
|
813 | (1) |
|
|
813 | (1) |
|
Prevalence and importance |
|
|
813 | (1) |
|
|
813 | (1) |
|
Central nervous system diseases |
|
|
814 | (7) |
|
|
814 | (2) |
|
|
816 | (1) |
|
|
816 | (2) |
|
|
818 | (1) |
|
|
819 | (1) |
|
Other neuromuscular disorders |
|
|
819 | (1) |
|
|
820 | (1) |
|
Amyotrophic lateral sclerosis |
|
|
821 | (1) |
|
Idiopathic upper esophageal sphincter dysfunction |
|
|
821 | (15) |
|
|
822 | (1) |
|
|
822 | (2) |
|
General approach to oropharyngeal dysphagia |
|
|
824 | (1) |
|
|
825 | (1) |
|
|
826 | (2) |
|
Distal esophageal spasm and related disorders |
|
|
828 | (1) |
|
Esophagogastric junction outflow obstruction (EGJO) |
|
|
829 | (1) |
|
|
830 | (1) |
|
|
830 | (2) |
|
|
832 | (1) |
|
|
832 | (1) |
|
|
833 | (1) |
|
|
834 | (1) |
|
Medication-induced esophageal injury |
|
|
835 | (1) |
|
|
836 | (1) |
|
|
836 | (1) |
|
|
837 | |
Index |
|
85 | |